We added a new product to our line of cardiovascular drugs, a selective β-blocker ATENOLOL JADRAN.
Atenonolol’s long-term administration in clinical practice for the treatment of hypertension, angina, heart arrhythmia and myocardial infarction has made it a synonym for the entire β-blocker group.
Atenolol Jadran is on the CIHI primary list of drugs.
tablets 30 x 50 mg
20 x 100 mg